Skip to main content
Clinical Trials/EUCTR2014-000202-35-FR
EUCTR2014-000202-35-FR
Active, not recruiting
Phase 1

Prevention of early ventilator-associated pneumonia with antibiotic therapy in patients treated with mild therapeutic hypothermia after cardiac arrest. Randomized, multicenter double-blind placebo-controlled trial. - ANTHARTIC

CHU de LIMOGES0 sites194 target enrollmentJune 22, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CHU de LIMOGES
Enrollment
194
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2015
End Date
September 14, 2017
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU de LIMOGES

Eligibility Criteria

Inclusion Criteria

  • \-Patients older than 18 years\-old, mechanically ventilated after an out\-of\-hospital resuscitated cardiac arrest secondary to shockable rhythm
  • \-Hospitalized in an ICU
  • \-Mild therapeutic hypothermia procedure scheduled (24 to 36 hours) before randomization
  • \-Delay from ROSC to randomisation \< 6 hours
  • \-Consent from family members or emergency consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 92
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • \-Pregnant women
  • \-Out\-of\-hospital cardiac arrest secondary to non shockable rhythm (mild therapeutic hypothermia not yet evidence based”)
  • \-In\-hospital cardiac arrest
  • \-Need for cardiac support by cardiopulmonary bypass
  • \-Ongoing antibiotic therapy or during the week before
  • \-Ongoing or concomitant pneumonia
  • \-Known chronic colonization with MRB
  • \-Known severe allergy to beta\-lactame antibiotics (Quincke edema, shock) and amoxicillin\-clavulanic acid use contraindications
  • \-Previous lung disease making radiological interpretation difficult for VAP diagnosis
  • \-Predictable decision of early care limitation or withdrawal (\< 7 days)

Outcomes

Primary Outcomes

Not specified

Similar Trials